Ventilator-associated pneumonia is characterized by excessive release of neutrophil proteases in the lung

Chest

Volumn 142, Issue 6, 2012, Pages 1425-1432

  Wilkinson, Thomas S ^a,b   Conway Morris, Andrew ^a   Kefala, Kallirroi ^a   O'Kane, Cecilia M ^c   Moore, Norma R ^d   Booth, Nuala A ^d   McAuley, Daniel F ^c   Dhaliwal, Kevin ^a   Walsh, Timothy S ^a   Haslett, Christopher ^a   Sallenave, Jean Michel ^e   Simpson, A John ^a,f  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b SWANSEA UNIVERSITY   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

^e INSERM   (France)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; INTERSTITIAL COLLAGENASE; LEUKOCYTE ELASTASE; LEUKOCYTE ELASTASE INHIBITOR; MATRILYSIN; METICILLIN; NEUTROPHIL COLLAGENASE; PLASMINOGEN ACTIVATOR; PROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANAEROBIC BACTERIUM; AREA UNDER THE CURVE; ARTICLE; ARTIFICIAL VENTILATION; ASPERGILLUS FUMIGATUS; BACTERIUM ISOLATION; CANDIDA ALBICANS; CELL FREE SYSTEM; CITROBACTER KOSERI; COAGULASE NEGATIVE STAPHYLOCOCCUS; COLONY FORMING UNIT; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; ESCHERICHIA COLI; FEMALE; HUMAN; HUMAN CELL; KLEBSIELLA PNEUMONIAE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PATHOGENESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SERRATIA MARCESCENS; VENTILATOR ASSOCIATED PNEUMONIA; ZYMOGRAPHY;

EID: 84870607793     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-3273     Document Type: Article

References (48)

1. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165(7):867-903. (Pubitemid 34774654)
2. Fagon JY, Chastre J, Vuagnat A, Trouillet JL, Novara A, Gibert C. Nosocomial pneumonia and mortality among patients in intensive care units. JAMA. 1996;275(11):866-869. (Pubitemid 26087224)
3. Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med. 1998;129(6):433-440. (Pubitemid 28428078)
4. Fagon JY, Chastre J, Wolff M, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med. 2000;132(8):621-630. (Pubitemid 30217554)
5. Canadian Critical Care Trials Group. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med. 2006;355(25):2619-2630.
6. Conway Morris A, Kefala K, Wilkinson TS, et al. Diagnostic importance of pulmonary interleukin-1beta and interleukin-8 in ventilator-associated pneumonia. Thorax. 2010;65(3):201-207.
7. Conway Morris A, Kefala K, Wilkinson TS, et al. C5a mediates peripheral blood neutrophil dysfunction in critically ill patients. Am J Respir Crit Care Med. 2009;180(1):19-28.
8. Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood. 1997;89(10):3503-3521. (Pubitemid 27227073)
9. Segal AW. How neutrophils kill microbes. Annu Rev Immunol. 2005;23:197-223. (Pubitemid 40563169)
10. Belaaouaj A, Kim KS, Shapiro SD. Degradation of outer membrane protein A in Escherichia coli killing by neutrophil elastase. Science. 2000;289(5482):1185-1188.
11. Sallenave JM, Morgan K, Gauldie J, Kalsheker N. Elastase inhibitors in the lung: expression and functional relationships. In: Stockley RA, ed. Molecular Biology of the Lung. Volume 1: Emphysema and Infection. Basel, Switzerland: Birkhäuser Verlag; 1999:69-93.
12. Brew K, Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta. 2010;1803(1):55-71.
13. Gadek JE, Fells GA, Zimmerman RL, Rennard SI, Crystal RG. Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema. J Clin Invest. 1981;68(4):889-898. (Pubitemid 11023517)
14. Birrer P, McElvaney NG, Rüdeberg A, et al. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am J Respir Crit Care Med. 1994;150(1):207-213. (Pubitemid 24209960)
15. Stockley RA, Hill SL, Morrison HM, Starkie CM. Elastolytic activity of sputum and its relation to purulence and to lung function in patients with bronchiectasis. Thorax. 1984;39(6):408-413. (Pubitemid 14107114)
16. Donnelly SC, MacGregor I, Zamani A, et al. Plasma elastase levels and the development of the adult respiratory distress syndrome. Am J Respir Crit Care Med. 1995;151(5):1428-1433.
17. Betsuyaku T, Nishimura M, Takeyabu K, et al. Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Am J Respir Crit Care Med. 1999;159(6):1985-1991. (Pubitemid 29275073)
18. Ratjen F, Hartog CM, Paul K, Wermelt J, Braun J. Matrix metalloproteases in BAL fluid of patients with cystic fibrosis and their modulation by treatment with dornase alpha. Thorax. 2002;57(11):930-934. (Pubitemid 35316269)
19. Fligiel SE, Standiford T, Fligiel HM, et al. Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury. Hum Pathol. 2006;37(4):422-430.
20. O'Kane CM, McKeown SW, Perkins GD, et al. Salbutamol up-regulates matrix metalloproteinase-9 in the alveolar space in the acute respiratory distress syndrome. Crit Care Med. 2009;37(7):2242-2249.
21. Nakstad B, Lyberg T, Skjønsberg OH, Boye NP. Local activation of the coagulation and fibrinolysis systems in lung disease. Thromb Res. 1990;57(6):827-838. (Pubitemid 20148998)
22. Fuchs-Buder T, de Moerloose P, Ricou B, et al. Time course of procoagulant activity and D dimer in bronchoalveolar fluid of patients at risk for or with acute respiratory distress syndrome. Am J Respir Crit Care Med. 1996;153(1):163-167. (Pubitemid 26026844)
23. Prabhakaran P, Ware LB, White KE, Cross MT, Matthay MA, Olman MA. Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2003;285(1):L20-L28. (Pubitemid 36736464)
24. Booth NA. Fibrinolysis and thrombosis. Best Pract Res Clin Haematol. 1999; 12(3):423-433. (Pubitemid 30312620)
25. Bertozzi P, Astedt B, Zenzius L, et al. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med. 1990;322(13):890-897. (Pubitemid 20108378)
26. Kotani I, Sato A, Hayakawa H, Urano T, Takada Y, Takada A. Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis. Thromb Res. 1995;77(6):493-504.
27. Fagon JY, Chastre J, Hance AJ, et al. Detection of nosocomial lung infection in ventilated patients. Use of a protected specimen brush and quantitative culture techniques in 147 patients. Am Rev Respir Dis. 1988;138(1):110-116.
28. Meduri GU, Mauldin GL, Wunderink RG, et al. Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. Chest. 1994;106(1):221-235. (Pubitemid 24214755)
29. Yu VL. Guidelines for hospital-acquired pneumonia and health-care-associated pneumonia: a vulnerability, a pitfall, and a fatal flaw. Lancet Infect Dis. 2011;11(3):248-252.
30. Kett DH, Cano E, Quartin AA, et al; Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Investigators. Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. Lancet Infect Dis. 2011;11(3):181-189.
31. Bernard GR, Artigas A, Brigham KL, et al The Consensus Committee. Report of the American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. Intensive Care Med. 1994;20(3):225-232. (Pubitemid 24088590)
32. Baselski VS, Wunderink RG. Bronchoscopic diagnosis of pneumonia. Clin Microbiol Rev. 1994;7(4):533-558. (Pubitemid 24317878)
33. Rennard SI, Basset G, Lecossier D, et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol. 1986;60(2):532-538. (Pubitemid 16019939)
34. Bennett B, Croll A, Ferguson K, Booth NA. Complexing of tissue plasminogen activator with PAI-1, alpha 2-macroglobulin, and C1-inhibitor: studies in patients with defibrination and a fibrinolytic state after electroshock or complicated labor. Blood. 1990;75(3):671-676. (Pubitemid 20069207)
35. Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32-35.
36. el-Ebiary M, Torres A, González J, et al. Use of elastin fibre detection in the diagnosis of ventilator associated pneumonia. Thorax. 1995;50(1):14-17.
37. Mathy-Hartert M, Damas P, Nys M, et al. Nitrated proteins in bronchoalveolar lavage fluid of patients at risk of ventilator-associated bronchopneumonia. Eur Respir J. 2000;16(2):296-301. (Pubitemid 30624949)
38. Hartog CM, Wermelt JA, Sommerfeld CO, Eichler W, Dalhoff K, Braun J. Pulmonary matrix metalloproteinase excess in hospital-acquired pneumonia. Am J Respir Crit Care Med. 2003;167(4):593-598.
39. Schaaf B, Liebau C, Kurowski V, Droemann D, Dalhoff K. Hospital acquired pneumonia with high-risk bacteria is associated with increased pulmonary matrix metalloproteinase activity. BMC Pulm Med. 2008;8:12.
40. El-Solh AA, Amsterdam D, Alhajhusain A et al. Matrix metalloproteases in bronchoalveolar lavage fluid of patients with type III Pseudomonas aeruginosa pneumonia. 2009;59(1):49-55.
41. El Solh AA, Akinnusi ME, Wiener-Kronish JP, Lynch SV, Pineda LA, Szarpa K. Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia. Am J Respir Crit Care Med. 2008;178(5):513-519.
42. Choi G, Schultz MJ, van Till JW, et al. Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection. Eur Respir J. 2004;24(5):786-789. (Pubitemid 39504432)
43. Schultz MJ, Millo J, Levi M, et al. Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia. Thorax. 2004;59(2):130-135. (Pubitemid 38223484)
44. El-Solh AA, Okada M, Pietrantoni C, Aquilina A, Berbary E. Procoagulant and fibrinolytic activity in ventilator-associated pneumonia: impact of inadequate antimicrobial therapy. Intensive Care Med. 2004;30(10):1914-1920. (Pubitemid 39468413)
45. Srinivasan R, Song Y, Wiener-Kronish J, Flori HR. Plasminogen activation inhibitor concentrations in bronchoalveolar lavage fluid distinguishes ventilator-associated pneumonia from colonization in mechanically ventilated pediatric patients. Pediatr Crit Care Med. 2011;12(1):21-27.
46. Suter PM, Suter S, Girardin E, Roux-Lombard P, Grau GE, Dayer JM. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis. 1992;145(5):1016-1022.
47. Idell S, James KK, Levin EG, et al. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest. 1989;84(2):695-705. (Pubitemid 19197006)
48. Sallenave JM, Donnelly SC, Grant IS, Robertson C, Gauldie J, Haslett C. Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome. Eur Respir J. 1999;13(5):1029-1036. (Pubitemid 29288925)